Applicable groups of Vigabatrin

Vigabatrin () is an anti-epileptic drug mainly used in patients with certain types of epilepsy, especially when other treatments are ineffective or intolerable. The applicable groups of this drug include the following categories:

Vibatrin is a first-line treatment for infantile spasms, a common epileptic encephalopathy in infancy. For these children, early use of Vigabatrin can help quickly control spasticity, reduce seizure frequency, and in some cases improve neurodevelopment. Clinical studies have shown that Vigabatrin has a better control effect on infantile spasms, and can be used as the drug of choice, especially when initial attacks are frequent.

Vibatrin is also indicated for adults and children with refractory partial epilepsy. For patients who do not respond well to other anti-epileptic drugs, Vibatrin can be used as an adjunctive medication to help control seizures and improve quality of life. However, because this drug has certain side effects, doctors will strictly evaluate the patient's condition and tolerance before deciding to use it.

Some patients with epilepsy may consider using Vigabatrin due to poor tolerance or insufficient efficacy of other drugs. Vigabatrin, as a unique anti-epileptic drug, inhibits the metabolism of gamma-aminobutyric acid (GABA), thereby enhancing the effect of inhibitory neurotransmitters and helping to control seizure frequency.

It should be noted that Vigabatrin is not suitable for all patients with epilepsy. This drug is generally not recommended in patients who are at increased risk of visual impairment, especially those with severe visual field defects. Additionally, Vigabatrin is not suitable for routine epilepsy treatment and should only be considered when other medications are ineffective.

In summary, Vigabatrin is indicated for patients with certain types of epilepsy, especially infantile spasms and refractory partial epilepsy. Patients should take medication under the guidance of a doctor to avoid risks such as adverse reactions and vision damage.